首页> 外文期刊>Hepatitis Monthly >THE EVALUATION OF HEPATITIS C VIRUS CORE ANTIGEN IN IMMUNIZED BALB/C MICE
【24h】

THE EVALUATION OF HEPATITIS C VIRUS CORE ANTIGEN IN IMMUNIZED BALB/C MICE

机译:免疫BALB / C小鼠丙型肝炎病毒核心抗原的评价。

获取原文
获取外文期刊封面目录资料

摘要

Background: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project.Objectives: The aim of the present study is to evaluate the role of HCV core protein in inducing IFn-Gamma secretion and TCL activities as a vaccine in Balb/C mice.Material and Methods: our previous cloned plasmid (HCV Core gene into peTDuet-1) applied for protein expression in bacteria. The expressed and purified recombinant protein together with Freund’s adjuvant was injected to 15 Balb/c mice. The total IgG and IgG2a of immunized mice sera were evaluated after a week. Two weeks after booster injection, we studied the proliferation and IFnγ secretion of spleens, inguinal and popliteal lymph nodes lymphocytes by eLISA and eLISPoT.Results: The FSFC (Frequency of spot forming cells) of secreting cells of immunized mice with HCV/Core protein and sera IgG2a were considerably higher than the control groups.Conclusion: The core protein together with proper adjuvant can be a candidate vaccine against of HCV infection.
机译:背景:肝炎感染是发展中国家发病率和死亡率的重要原因之一,但是目前尚无有效的丙型肝炎疫苗,这是疫苗项目中的重大问题之一。目的:本研究的目的是评估HCV核心蛋白在Balb / C小鼠中作为疫苗诱导IFn-γ分泌和TCL活性的作用。材料与方法:我们以前克隆的质粒(将HCV核心基因插入peTDuet-1)用于细菌中的蛋白表达。将表达和纯化的重组蛋白与弗氏佐剂一起注射到15只Balb / c小鼠中。一周后评估免疫小鼠血清的总IgG和IgG2a。加强注射后两周,我们通过eLISA和eLISPoT研究了脾脏,腹股沟和小肠淋巴结淋巴细胞的增殖和IFnγ分泌。结果:用HCV / Core蛋白和结论:核心蛋白和适当的佐剂可以作为抗HCV感染的候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号